All lobbying filings

FEDERAL HEALTH POLICY STRATEGIES

Lobbying for MEDICATION ASSISTED TREATMENT LEADERSHIP COUNCIL · Opioid treatment program facilities and practices

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 18, 2025

Income

$50,000

What the client paid this registrant for the period.

Client based in

Texas

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Modernizing Opioid Treatment Access Act (S. 1359/H.R. 644) Access to medication-assisted treatment and Medicaid reform

Bills named in this filing 2

S. 1359
STOP CCP Act of 2025
H.R. 644
Harmful Algal Bloom and Hypoxia Research and Control Amendments Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.